Back to 
RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P.
FDMTShowing 8 of 13 quarters
Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in 4D MOLECULAR THERAPEUTICS IN
RA CAPITAL MANAGEMENT, L.P. holds 5M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $67.2M as of 2026-Q2. FDMT represents 0.6% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.
Current Value
$67.2M
Current Shares
5M
Total Value Change
+$12.1M
Total Shares Change
-48,432
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, BlackRock Finance, Inc.